Transcriptomics

Dataset Information

0

An improved protocol for targeted differentiation of human iPSCs into HLA-G expressing trophoblasts cells enabling modelling of placenta-related disorders.


ABSTRACT: Abnormalities at any stage of trophoblast development may result in pregnancy-related com-plications. Many of these adverse outcomes are discovered later in pregnancy, but the underly-ing pathomechanisms constitute during the first trimester. Acquiring developmentally relevant material to elucidate the disease mechanisms is difficult. Human pluripotent stem cell (hPSC) technology can provide a renewable source of relevant cells. BMP4, A83-01, and PD173074 (BAP) treatment drives trophoblast commitment of hPSCs towards syncytiotrophoblast (STB) but lacks extravillous trophoblast (EVT) cells. EVTs mediate key functions during placentation, remodel-ing of uterine spiral arteries, and maintenance of immunological tolerance. We optimized the protocol for more efficient generation of HLA-Gpos EVT-like trophoblasts from primed hiPSCs. Increasing the concentrations of A83-01 and PD173074, while decreasing bulk cell density re-sulted in the increase of HLA-G of up to 71%. Gene expression profiling support the advance-ments of our treatment regarding the generation of trophoblast cells. The reported differentia-tion protocol will allow the on-demand access to human trophoblast cells enriched for HLA-Gpos EVT-like cells, allowing the elucidation of placenta-related disorders and to investigate the im-munological tolerance towards the fetus, overcoming the difficulties in obtaining primary EVTs without the need for a complex differentiation pathway via naïve pluripotent or trophoblast stem cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE234949 | GEO | 2023/09/14

REPOSITORIES: GEO

Similar Datasets

2023-02-09 | E-MTAB-12650 | biostudies-arrayexpress
2015-08-31 | E-GEOD-64272 | biostudies-arrayexpress
2024-01-10 | E-MTAB-13379 | biostudies-arrayexpress
2010-09-23 | E-GEOD-20510 | biostudies-arrayexpress
2022-05-20 | PXD033289 | Pride
2023-06-18 | GSE207630 | GEO
| EGAD00001010017 | EGA
2015-06-11 | GSE62065 | GEO
2024-01-10 | E-MTAB-13382 | biostudies-arrayexpress
2024-03-27 | GSE243579 | GEO